# PAC-ATLS: Postapproval Changes - Analytical Testing Laboratory Sites:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/pac-atls-postapproval-changes-analytical-testing-laboratory-sites-guidance-for-industry/655cb6dd-896b-4f24-b17a-5f1c796c873e

> FDA guidance document: PAC-ATLS: Postapproval Changes - Analytical Testing Laboratory Sites:  Guidance for Industry. Issue date: April 28, 1998. Get complete insights and analysis.

---

## Details

- Title: PAC-ATLS: Postapproval Changes - Analytical Testing Laboratory Sites:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1998-04-28
- Last Changed: 2020-05-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1998-D-1157">FDA-1998-D-1157</a>

## Related Documents

- [Expiration Dating and Stability Testing of Solid Oral Dosage Form Drugs Containing Iron:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/expiration-dating-and-stability-testing-of-solid-oral-dosage-form-drugs-containing-iron-guidance-for-industry/e8fd7f66-c062-4a8a-bc7b-40e37119c3cb)
- [Changes to an Approved NDA or ANDA: Questions and Answers:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/changes-to-an-approved-nda-or-anda-questions-and-answers-guidance-for-industry/35e76fcd-a993-489c-8472-73c4bbb60d94)
- [National Uniformity for Nonpresciption Drugs - Ingredient Listing for OTC Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/national-uniformity-for-nonpresciption-drugs-ingredient-listing-for-otc-drugs/9d832005-d340-46af-95c2-1e3fa3b3ab8b)